{"id":11851,"date":"2024-09-16T17:45:00","date_gmt":"2024-09-16T15:45:00","guid":{"rendered":"https:\/\/www.maunakeatech.com\/?p=11851"},"modified":"2024-09-16T17:24:58","modified_gmt":"2024-09-16T15:24:58","slug":"mauna-kea-technologies-announces-ground-breaking-positive-clinical-results-in-lung-cancer-obtained-with-cellvizio","status":"publish","type":"post","link":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-ground-breaking-positive-clinical-results-in-lung-cancer-obtained-with-cellvizio\/","title":{"rendered":"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0"},"content":{"rendered":"\n<p class=\"has-text-align-center\"><strong><em>Recent clinical study published in Journal of Thoracic Disease supports the combination of Cellvizio with Electromagnetic Navigation Bronchoscopy to improve diagnosis and treatment of lung cancer&nbsp;<\/em><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong><em>Cellvizio\u2019s sensitivity of 96.43% and specificity of 100% in characterizing malignancies enabled higher diagnostic yield and radiation-free nodule marking for surgical resection&nbsp;<\/em><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong><em>Lung cancer remains the leading cause of cancer-related deaths worldwide with 2.5 million new cases annually&nbsp;<\/em><\/strong><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>Paris and Boston, September 16, 2024 \u2013 5:45 p.m. CEST \u2013 Mauna Kea Technologies (Euronext Growth: ALMKT)<\/strong>, inventor of Cellvizio<sup>\u00ae<\/sup>, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announces the publication1 in the peer-reviewed <em>Journal of Thoracic Disease <\/em>of new ground-breaking clinical results demonstrating the efficacy of its needle-based Confocal Laser Endomicroscopy (nCLE) technology for the characterization of peripheral lung cancer and preparation of surgical resection.\u00a0<\/p>\n\n\n\n<p>This study, conducted by the team of Professor St\u00e9phane Renaud at the University Hospital of Nancy, evaluated the use of Cellvizio\u2019s nCLE platform in combination with Electromagnetic Navigation Bronchoscopy (ENB) to characterize suspicious pulmonary nodules and prepare them for surgical resection when needed. The results highlight the potential of nCLE to rapidly and accurately identify malignant lesions while minimizing the risks associated with traditional diagnostic methods including ionizing radiation.&nbsp;<\/p>\n\n\n\n<p>The study included 30 patients with suspicious pulmonary nodules with a median size of 16 mm. The findings revealed a sensitivity of 96.43% and a specificity of 100% in characterizing malignant lesions, based on previously published nCLE image classification. The median time of contact with the suspicious lesions was just 5 minutes with no major complications reported, demonstrating the technology&#8217;s efficiency in clinical practice. Additionally, the use of nCLE also improved the quality and quantity of tissue sampling, thus enabling molecular and genomics analyses, which have become essential tools for the choice and planning of treatments.&nbsp;<\/p>\n\n\n\n<p><strong>Professor St\u00e9phane Renaud, Thoracic Surgeon at University Hospital Nancy and principal investigator of the study<\/strong>, stated: <em>&#8220;We are extremely pleased with the results of this study, which brings to light the high diagnostic value of needle-based endomicroscopy in combination with Electromagnetic Navigation Bronchoscopy and its ability to improve our treatment planning and minimize patient risk. With a much-enhanced ability to target our biopsies, we have also been able to obtain essential tissue material for molecular and genomics analyses,&nbsp;<\/em><em>which are crucial for guiding immunotherapy strategies. This combination of technologies will certainly play a key role in the fight against lung cancer in the future.\u201d&nbsp;<\/em><\/p>\n\n\n\n<p><em>&#8220;We are thrilled by these outstanding clinical results, which reinforce the value of our needle-based endomicroscopy platform in advancing the field of lung cancer diagnostics and treatment\u201d, <\/em>commented <strong>Sacha Loiseau, Ph.D., Chairman and CEO of Mauna Kea Technologies<\/strong>. \u201c<em>This study confirms that Cellvizio<sup>\u00ae<\/sup> can play a pivotal role not only in enabling real-time, accurate, and minimally invasive diagnosis, but also in helping physicians improve their treatment planning and, in turn, patient outcomes.&#8221;&nbsp;<\/em><br><br><sup>1 <\/sup>\u201cAssessment of needle-based confocal laser endomicroscopy (nCLE) as a tool for real-time diagnosis of non-small cell lung cancer\u201d https:\/\/jtd.amegroups.org\/article\/view\/89316\/html&nbsp;<\/p>\n\n\n\n<p><a href=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/09\/PR_ALMKT_Renaud-Lung-Study.pdf\">READ THE FULL PRESS RELEASE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recent clinical study published in Journal of Thoracic Disease supports the combination of Cellvizio with Electromagnetic Navigation Bronchoscopy to improve diagnosis and treatment of lung cancer&nbsp; Cellvizio\u2019s sensitivity of 96.43% and specificity of 100% in characterizing malignancies enabled higher diagnostic yield and radiation-free nodule marking for surgical resection&nbsp; Lung cancer remains the leading cause of [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":4402,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[34],"tags":[],"class_list":["post-11851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-int"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0 - Mauna Kea Technologies<\/title>\n<meta name=\"description\" content=\"Mauna Kea Technologies announces the publication in the peer-reviewed Journal of Thoracic Disease of new ground-breaking clinical results demonstrating the efficacy of its needle-based Confocal Laser Endomicroscopy (nCLE) technology for the characterization of peripheral lung cancer and preparation of surgical resection.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maunakeatech.com\/?p=11847\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0 - Mauna Kea Technologies\" \/>\n<meta property=\"og:description\" content=\"Mauna Kea Technologies announces the publication in the peer-reviewed Journal of Thoracic Disease of new ground-breaking clinical results demonstrating the efficacy of its needle-based Confocal Laser Endomicroscopy (nCLE) technology for the characterization of peripheral lung cancer and preparation of surgical resection.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maunakeatech.com\/?p=11847\" \/>\n<meta property=\"og:site_name\" content=\"Mauna Kea Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/maunakeatech\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-16T15:45:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"192\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elizabeth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:site\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elizabeth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847\"},\"author\":{\"name\":\"Elizabeth\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/46a359c122ceb464208dd447ff0dea82\"},\"headline\":\"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0\",\"datePublished\":\"2024-09-16T15:45:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847\"},\"wordCount\":522,\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"int\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847\",\"name\":\"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0 - Mauna Kea Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"datePublished\":\"2024-09-16T15:45:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/46a359c122ceb464208dd447ff0dea82\"},\"description\":\"Mauna Kea Technologies announces the publication in the peer-reviewed Journal of Thoracic Disease of new ground-breaking clinical results demonstrating the efficacy of its needle-based Confocal Laser Endomicroscopy (nCLE) technology for the characterization of peripheral lung cancer and preparation of surgical resection.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847#breadcrumb\"},\"inLanguage\":\"int\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847#primaryimage\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"contentUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"width\":330,\"height\":192},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/?p=11847#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.maunakeatech.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/\",\"name\":\"Mauna Kea Technologies\",\"description\":\"See Cells. Change Lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.maunakeatech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"int\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/46a359c122ceb464208dd447ff0dea82\",\"name\":\"Elizabeth\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g\",\"caption\":\"Elizabeth\"},\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/int\\\/author\\\/elizabeth\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0 - Mauna Kea Technologies","description":"Mauna Kea Technologies announces the publication in the peer-reviewed Journal of Thoracic Disease of new ground-breaking clinical results demonstrating the efficacy of its needle-based Confocal Laser Endomicroscopy (nCLE) technology for the characterization of peripheral lung cancer and preparation of surgical resection.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maunakeatech.com\/?p=11847","og_locale":"en_US","og_type":"article","og_title":"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0 - Mauna Kea Technologies","og_description":"Mauna Kea Technologies announces the publication in the peer-reviewed Journal of Thoracic Disease of new ground-breaking clinical results demonstrating the efficacy of its needle-based Confocal Laser Endomicroscopy (nCLE) technology for the characterization of peripheral lung cancer and preparation of surgical resection.\u00a0","og_url":"https:\/\/www.maunakeatech.com\/?p=11847","og_site_name":"Mauna Kea Technologies","article_publisher":"https:\/\/www.facebook.com\/maunakeatech\/","article_published_time":"2024-09-16T15:45:00+00:00","og_image":[{"width":330,"height":192,"url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","type":"image\/png"}],"author":"Elizabeth","twitter_card":"summary_large_image","twitter_creator":"@maunakeatech","twitter_site":"@maunakeatech","twitter_misc":{"Written by":"Elizabeth","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maunakeatech.com\/?p=11847#article","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/?p=11847"},"author":{"name":"Elizabeth","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"headline":"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0","datePublished":"2024-09-16T15:45:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maunakeatech.com\/?p=11847"},"wordCount":522,"image":{"@id":"https:\/\/www.maunakeatech.com\/?p=11847#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","articleSection":["News"],"inLanguage":"int"},{"@type":"WebPage","@id":"https:\/\/www.maunakeatech.com\/?p=11847","url":"https:\/\/www.maunakeatech.com\/?p=11847","name":"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0 - Mauna Kea Technologies","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maunakeatech.com\/?p=11847#primaryimage"},"image":{"@id":"https:\/\/www.maunakeatech.com\/?p=11847#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","datePublished":"2024-09-16T15:45:00+00:00","author":{"@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82"},"description":"Mauna Kea Technologies announces the publication in the peer-reviewed Journal of Thoracic Disease of new ground-breaking clinical results demonstrating the efficacy of its needle-based Confocal Laser Endomicroscopy (nCLE) technology for the characterization of peripheral lung cancer and preparation of surgical resection.\u00a0","breadcrumb":{"@id":"https:\/\/www.maunakeatech.com\/?p=11847#breadcrumb"},"inLanguage":"int","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maunakeatech.com\/?p=11847"]}]},{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/www.maunakeatech.com\/?p=11847#primaryimage","url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","contentUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","width":330,"height":192},{"@type":"BreadcrumbList","@id":"https:\/\/www.maunakeatech.com\/?p=11847#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maunakeatech.com\/"},{"@type":"ListItem","position":2,"name":"Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.maunakeatech.com\/#website","url":"https:\/\/www.maunakeatech.com\/","name":"Mauna Kea Technologies","description":"See Cells. Change Lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maunakeatech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"int"},{"@type":"Person","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/46a359c122ceb464208dd447ff0dea82","name":"Elizabeth","image":{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/753cb731fb04a2510df64185e7f61d3644390bc126783463265dfb2418e724d9?s=96&d=mm&r=g","caption":"Elizabeth"},"url":"https:\/\/www.maunakeatech.com\/int\/author\/elizabeth\/"}]}},"_links":{"self":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/11851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/comments?post=11851"}],"version-history":[{"count":3,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/11851\/revisions"}],"predecessor-version":[{"id":11859,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/11851\/revisions\/11859"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media\/4402"}],"wp:attachment":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media?parent=11851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/categories?post=11851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/tags?post=11851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}